Accéder au contenu
Merck

ERG activity is regulated by endothelial FAK coupling with TRIM25/USP9x in vascular patterning.

Development (Cambridge, England) (2022-06-21)
Gabriela D'Amico, Isabelle Fernandez, Jesús Gómez-Escudero, Hyojin Kim, Eleni Maniati, Muhammad Syahmi Azman, Faraz K Mardakheh, Bryan Serrels, Alan Serrels, Maddy Parsons, Anthony Squire, Graeme M Birdsey, Anna M Randi, Alfonso Bolado-Carrancio, Rathi Gangeswaran, Louise E Reynolds, Natalia Bodrug, Yaohe Wang, Jun Wang, Pascal Meier, Kairbaan M Hodivala-Dilke
RÉSUMÉ

Precise vascular patterning is crucial for normal growth and development. The ERG transcription factor drives Delta-like ligand 4 (DLL4)/Notch signalling and is thought to act as a pivotal regulator of endothelial cell (EC) dynamics and developmental angiogenesis. However, molecular regulation of ERG activity remains obscure. Using a series of EC-specific focal adhesion kinase (FAK)-knockout (KO) and point-mutant FAK-knock-in mice, we show that loss of ECFAK, its kinase activity or phosphorylation at FAK-Y397, but not FAK-Y861, reduces ERG and DLL4 expression levels together with concomitant aberrations in vascular patterning. Rapid immunoprecipitation mass spectrometry of endogenous proteins identified that endothelial nuclear-FAK interacts with the deubiquitinase USP9x and the ubiquitin ligase TRIM25. Further in silico analysis confirms that ERG interacts with USP9x and TRIM25. Moreover, ERG levels are reduced in FAKKO ECs via a ubiquitin-mediated post-translational modification programme involving USP9x and TRIM25. Re-expression of ERG in vivo and in vitro rescues the aberrant vessel-sprouting defects observed in the absence of ECFAK. Our findings identify ECFAK as a regulator of retinal vascular patterning by controlling ERG protein degradation via TRIM25/USP9x.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
(Z)-4-Hydroxytamoxifène, ≥98% Z isomer
Sigma-Aldrich
Fibronectine plasmatique humaine, protéine purifiée, from human plasma, liquid, 1 mg/mL (100 MG pack size is lyophilized), purified protein, suitable for cell culture
Sigma-Aldrich
Collagène de type I solution from rat tail, BioReagent, suitable for cell culture, sterile-filtered
Sigma-Aldrich
MG-132, A cell-permeable, potent, reversible proteasome inhibitor (Ki = 4 nM).
Sigma-Aldrich
Anticorps anti-glycéraldéhyde-3-phosphate déshydrogénase, clone 6C5, clone 6C5, Chemicon®, from mouse
Sigma-Aldrich
Protease Inhibitor Cocktail Set I, A cocktail of five protease inhibitors that will inhibit a broad range of proteases and esterases. Supplied with a data sheet.
Sigma-Aldrich
Mouse IgG−Agarose, (Suspension in 0.5 M NaCl containing preservative.)
Millipore
Protease Inhibitor Cocktail Set II, The Protease Inhibitor Cocktail Set II controls the activity of Protease. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.
Sigma-Aldrich
Anticorps anti-FAK, clone 4.47, clone 4.47, Upstate®, from mouse
Millipore
Phosphatase Inhibitor Cocktail Set III, Lyophilized, The Phosphatase Inhibitor Cocktail Set III, Lyophilized controls the activity of Phosphatase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.
Sigma-Aldrich
Anti-FAK Antibody, clone 4.47, agarose conjugate, clone 4.47, Upstate®, from mouse